Recently approved drugs offer significant improvements for treatment options in pulmonary arterial hypertension

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.4, 2006-04, pp. : 11-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacologic Treatment of Pulmonary Arterial Hypertension

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 3963-3973

Bentham Science Publishers

Access to resources Recommend Favorite

New Insights in the Treatment Strategy for Pulmonary Arterial Hypertension

By Sahara Makoto Takahashi Toshiyuki Imai Yasushi Nakajima Toshiaki Yao Atsushi Morita Toshihiro Hirata Yasunobu Nagai Ryozo

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 377-386

Springer Publishing Company

Access to resources Recommend Favorite

Targeted Oral Therapies in the Treatment of Pulmonary Arterial Hypertension

By Safdar Zeenat

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 811-826

Adis International

Access to resources Recommend Favorite

Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

By O'Callaghan Dermot S Savale Laurent Yaïïci Azzedine Natali Delphine Jaïïs Xavier Parent Florence Montani David Humbert Marc Simonneau Géérald Sitbon Olivier

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1585-1596

Informa Healthcare

Access to resources Recommend Favorite

Iloprost inhalation solution for the treatment of pulmonary arterial hypertension

By Hsu Henry H Rubin Lewis J

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1921-1930

Informa Healthcare

Access to resources Recommend Favorite